Researchphoto
Types of DisordersComprehensive CareResearchPresentationsResourcesNewsContact UsHome
 
Current Research Studies

 • The Effects of NN1731 and High-Dose rFVIIa in Severe Hemophiliacs Poorly Responsive to in In Vivo Dosing of rFVIIa 90 mcg/kg (enrolling fall of 2009)

 • Correlation between Vitamin D status and Bone Mineral Density in Patients with Hemophilia A (enrolling fall of 2009)

 • CHAVI 014 Investigation of Gene Variants Associated with Resistance and Susceptibility to HIV (enrolling summer of 2009) 

• Phase I Trial of Pegylated Recombinant Factor IX (enrolling summer of 2009)

• Universal Data and Serum Collection Study, sponsored by the Centers for Disease Control (currently enrolling)

• Universal Data and Serum Collection Study Inhibitor Pilot Addendum, sponsored by the Centers for Disease Control (currently enrolling)

 




VCU Health System | Central Virginia Center for Coagulation Disorders
P.O. Box 980461 | Richmond, VA | 23298-0461
phone: (804) 827-3306 | toll free: (866) 288-2516 | fax: (804) 692-0291

contact us
| acknowledgments
last updated: 03/30/2009
Central Virginia Center for Coagulation Disorders